Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
30 September
ENANTA PHARMACEUTICALS INC has filed 832 SEC EDGAR filings since 21 Jun 2002

SEC filing history

Showing 751-775 of 831 matching filings.

Per page
25
Current page
31
S-8 File 333-192935

S-8

Filing date
18 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Dec 2013
Reporting date
11 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

FORM 8-K

Filing date
10 Dec 2013
Reporting date
10 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Dec 2013
Reporting date
08 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Dec 2013
Reporting date
08 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Dec 2013
Reporting date
08 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Dec 2013
Reporting date
06 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Dec 2013
Reporting date
05 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Dec 2013
Reporting date
05 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Dec 2013
Reporting date
05 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Dec 2013
Reporting date
22 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
06 Dec 2013
Reporting date
22 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Nov 2013
Reporting date
26 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K

Filing date
26 Nov 2013
Reporting date
22 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K

Filing date
25 Nov 2013
Reporting date
22 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K

Filing date
18 Nov 2013
Reporting date
18 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR OCTOBER 11 AND 14 SALES (ENTA)

Filing date
16 Oct 2013
Reporting date
11 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR OCTOBER 9 SALES (ENTA)

Filing date
11 Oct 2013
Reporting date
09 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Oct 2013
Reporting date
02 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Oct 2013
Reporting date
30 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K

Filing date
03 Sep 2013
Reporting date
29 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

FORM 8-K

Filing date
21 Aug 2013
Reporting date
18 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

FORM 8-K

Filing date
12 Aug 2013
Reporting date
12 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .